Abstract. The aim of this study is to examine whether the retinopathy-free survival in diabetics is linked to the genotype at the Adose Reductase Locus. Two hundred and fifty-six Australian adolescents with type 1 diabetes were attending for complication, screenings were genotyped. One microsatellite at the aldose reductase was amplified by Polymerase chain reaction to produce fragments of 126-152 base pair (Z = 138). Kaplan-Meier survival analysis was used to determine the duration free of retinopathy according to genotypes Z-2/Z-2, Z-2/non Z-2 and non Z-2/non Z-2. A stereoscopic fundal photography was performed; blinded to the patients' genotype. The presence of a background retinopathy was defined as any microaneurysm or hemorrhage. The results of our study show that, Median survival free of retinopathy was significantly shorter in patients having the Z-2 allele (p = 0.014). When survival analysis was performed on combinations of both Z-2 and Z+2, the only significant difference was between Z+2/non Z+2 and non Z+2/non Z+2 (p = 0.04). We concluded that survival free of retinopathy was significantly reduced in Australian patients with a Z-2 allele with less evidence for other alleles. This may represent that some sort of protective mechanism of retinopathy in patients with absent Z-2 allele.
Introduction
Diabetes Control and Complications Trial (DCCT) [1] showed that the incidence of microvascular complications were significantly influenced by glycaemic control. In addition, familial clustering of retinopathy as well as nephropathy was identified when first degree relatives were also investigated [2] .
The aldose reductase gene (AR2) is a good candidate for this familial aggregation. A substantial evidence points to a key role for increased glucose metabolism by cytosolic enzyme, aldose reductase enzyme through the polyol pathway [3] . Polyol pathway is activated by hyperglycaemia. An elevated tissue level of AR2 were associated with diabetes complications [4] [5] [6] [7] . The discovery of the AR2 (AC)n dinucleotide repeats sequence at 2.1 kb upstream of the transcription start site was followed by the initial demonstration, that the Z-2 allele marker was associated with susceptibility for retinopathy in type 2 diabetes [8] . Subsequently, this allele was also linked to an increased risk of nephropathy in type 1 diabetes [9] . A more recent study has suggested that the repeat length, rather than a specific allele was important for retinopathy in type 2 diabetes [10] . Specifically in the Japanese population the Z-4 allele showed an association with retinopathy [11] . A protective effect of the Z+2 allele has been proposed [12] [13] .
Most individuals given sufficient diabetes duration, eventually developed retinopathy. A survival analysis was used in the current study to investigate whether the retinopathy-free survival period was linked to AR2 (AC)n dinucleotide a repeated sequence polymorphism.
Materials and Methods

Recruitment of Adolescents with Type 1 Diabetes with/without Microvascular Complications
Two hundred and fifty-six Australian adolescents with type 1 diabetes were sequentially genotyped when they attended for their annual complication screening. Stereoscopic fundal photography of seven standard fields was performed and a trained ophthalmologist, blinded to the patient's genotype, graded the photographs. Patients' characteristics are shown in Table 1 and 93% of this population is Caucasian. These measurements were those from the last annual assessment or those from the first assessment when retinopathy was detected. All participants gave informed consent, and the Hospital's Ethics Committee approved the study. Genotyping for 5′ AR2 (AC)n Dinucleotide Repeats Polymorphism Genotyping of patients was performed using genomic DNA prepared from white blood cells. The 5' AR2 (AC)n polymorphism was amplified by PCR using a FAM labeled oligonucleotide to produce fragments of 126-152 bp (Z = 138 bp). The primers used to amplify the region of interest were ARpr1 (5'-FAM-TGGTCAGGCCTGGCCCTCCT-3') and ARpr2 (5'-GATACCTCTCGGTGTGGCTGA-3') [8] . PCRs were performed in 20 µl reactions with 100 ng genomic DNA as a template, 5 pmol of each primer, 200 µM dNTPs, 25 mM MgCl 2 and 1 U Taq DNA polymerase (Boehringer Mannheim). Samples were subjected to 35 cycles of amplification using a touchdown protocol. Denaturation for 2 min at 95°C, annealing temperature was reduced by 2°C/cycle from 66 to 54°C for 1 min with the final 25 cycles at 54°C and extension at 72°C for 30 sec. PCR fragments were sized on an automated DNA sequencer (ABI 373) using a standard techniques. The size of the (AC)n allele was determined by comparison with previously genotyped specimens [13] .
Statistical Analysis
The software packages of SAS (Version 6.12, Cary NC, SAS Institute, 1996) and SPSS were used to analyze the data. Wilcoxon rank- Kaplan-Meier survival analysis was used to determine retinopathyfree survival for the three microsatellite alleles: Z-2, Z+2 and Z+4, as well as allele length shorter or longer than Z-2. Difference in survival times was tested by log rank test. P-values of less than 0.05 were considered statistically significant.
Results
The distribution of alleles of the AR2 polymorphism in our cohort is summarized in Table 2 . A total of fourteen alleles were observed (Z+14, Z+12, Z+10, Z+8, Z+6, Z+4, Z+2, Z, Z-2, Z-4, Z-6, Z-8, Z-10, Z-12). The three major alleles detected were Z-2, Z, and Z+2. There were no significant differences in allele distribution for those with and without retinopathy, when no correction was made for the significantly longer duration of those with retinopathy. Median retinopathy-free survival was significantly shorter in patients having the Z-2 allele (p = 0.014) ( Fig. 1 and Table 3 ). There was a significant difference in the retinopathy-free survival between those having any allele shorter than or equal to Z-2 allele and those with both alleles longer than Z+2 (p = 0.049). There was no significant difference in the survival time free of retinopathy according to the presence or absence of the Z+2 or the Z+4 allele (Table 3) . When survival analysis was performed on combinations of both Z-2 and Z+2, the only significant difference was between Z+2/non Z+2 and non Z+2/non Z+2 (p = 0.04).
HbA1c was surprisingly significantly lower in those with retinopathy on the day of assessment, but was not different when median of all measurements from diagnosis for an individual were analyzed (Table 1) .
Discussion
In the current study, survival free of retinopathy was significantly reduced in the group with the Z-2 allele of the AR2 microsatellite marker. This data does not support a susceptibility role for the Z+4 allele, nor a protective effect of the Z+2 allele.
The increased risk of retinopathy associated with the Z-2 allele is in agreement with the findings described in Chinese patients with type 2 diabetes [8] and in Caucasian patients with type 1 diabetes [12, 13] . However, there was no role for alleles shorter than Z-2 was found. Indeed, when the shorter alleles were included with Z-2, this actually negated the susceptibility risk. This contrasts with two Japanese studies of type 2 diabetes in which proliferative retinopathy was associated with alleles equal to or shorter than Z-2 [10] and with the Z-4 allele [11] .
Recent studies support a role for the upstream (AC)n repeat sequences, in modulating the expression level of AR2. In American and Italian patients with type 1 diabetes, AR2 mRNA levels were found higher in association with the Z-2 allele, but without diabetes, the Z-2 allele did not influence AR2 mRNA levels [14] . In type 2 Japanese patients, higher AR2 protein levels were found with the Z-4 allele [11] . Furthermore, in a retinal epithelial cell line, transfect with the Japanese Z-4 AR2 gene promoter region in a luciferase vector, gene transcription was up-regulated compared to constructs with other (AC)n repeat sequences, including the Z-2 construct.
It is tempting to speculate that the association of the Z-2 allele with diabetes complications seen in this study is equivalent to that of the Z-4 allele in Japanese patients. The Z-4 allele in Japanese patients and the Z-2 allele in other populations may both act epistatically with another susceptibility polymorphism in the AR2 gene or in other genetic loci. This discrepancy may reflect differences between type 1 and type 2 diabetes plus other genetic and environmental factors unique to the two populations.
The advantage of survival analysis in a longitudinal study over chisquared analysis in a case-control study is that the interaction between the study effect (AR2 allele) and time (diabetes duration) can be identified. Survival analysis also allows for different lengths of patient follow-up. The majority of the patients with diabetes developed diabetic retinopathy if followed for long enough: 98% after duration of 15 years or more [15] . In the current study the frequency of Z-2 allele was not significantly higher in the group with retinopathy who had slightly longer diabetes duration (Table 1 ), but its presence was associated with shorter survival free of retinopathy.
Survival analysis is a sensitive method to investigate the population significance of a single candidate gene, which may increase or decrease the risk of early onset of an outcome. Selection of patients based on the outcomes of a long duration absence or a short duration presence of a complication. In case control studies, does not provide clear evidence of whether susceptible or protective polymorphisms are sufficient in them or need to work in synergy with other genes to produce the effect. Indeed, the protective effect of the Z+2 allele has only been detected in the study of English type 1 diabetic subjects who survived 20 or more years without retinopathy [12] . The lack to identify the protective effect in the current study may be because of some other factor(s) which is also needed, and that only a small proportion of individuals with Z+2 are protected.
Environmental factors, presumably interact with genetic determinants to regulate gene expression and the risk for complications. However, hyperglycemia as measured by HbA 1c was surprisingly not higher in those with diabetic retinopathy in the current study. Similarly there was no effect seen for blood pressure.
Aldose reductase inhibition represents an attractive strategy for prevention of diabetic complications [16] . The beneficial effects of aldose reductase inhibitors (ARIs) in preventing or substantially delaying the onset of diabetic complications have largely been demonstrated in experimental models, in which the inhibition was initiated at onset of diabetes [17, 18] . If more is understood about susceptibility alleles in the aldose reductase gene, then specific individuals with such alleles may be targeted for intervention with aldose reductase inhibitors.
The current study supports an important role for the aldose reductase gene (AC)n dinucleotide to repeat a sequence of polymorphism in the early development of diabetic retinopathy.
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